SC Tablet Mini is a highly portable yet durable iPad-based speech generating device for people of all ages with communication impairments. Based on the iPad Mini 6, it comes pre-loaded with assistive communication apps, such as TD Snap and TD Talk, to empower people with communication impairments to express themselves and lead a more independent life.
Customers have been requesting a smaller and lighter iPad-based communication aid, and Tobii Dynavox listened. With its small size and low weight, the SC Tablet Mini will be ideal for example for children that need a portable and durable communication device to bring along in their daily active lives, as well as users with aphasia that need a discreet communication aid that they can always have by their side. This rugged device has a fitted silicone case to withstand drops, complete with reinforced corners, a screen-protecting frame, powerful integrated speakers and built-in handle and stand.
Read more about the SC Tablet Mini here: https://www.tobiidynavox.com/pages/sc-tablet
Tobii is the global leader in eye tracking. Our mission is to improve the world with technology that understands human attention and intent. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye tracking equipment and services used today by more than 3,500 companies and 2,500 research institutions, including 98 of the world’s 100 highest ranked universities. Tobii Tech supplies eye tracking technology for integration into consumer electronics and other products such as personal computers, virtual reality headsets, healthcare applications, automotive DMS and more. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 1,000 employees. For more information: www.tobii.com.__biE
You will receive an email to verify your email address and activate the subscription. You may close this dialog.
We could not save your subscription. Please close this dialog and try again.